Stock Taper
OPTH
OPTIMI HEALTH CORP.
NASDAQ
$4.78
▲ UP 1.60% (0.07)

KEY STATISTICS

Market Cap$15.20 M
52w High$6.40
52w Low$4.00
Dividend Yield
Frequency
P/E-17.48
Volume4.41K
Shares Out.3.22M

COMPANY

LEADERSHIP

Dane Stevens
CHIEF EXECUTIVE
Dane Stevens

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 20, 2026
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6

UPCOMING EARNINGS

DateFeb 2, 2027
DayTuesday
Rev. Est.$194.94K
FEB
2
TUE

SPLIT RECORD

DATETYPERATIO
2026-05-20Reverse1:30

PRICE

$4.78 ▲ UP 1.60% (+$0.07)
OVERLAYS
$4.72$4.80$4.889:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM4.78

About Optimi Health Corp.

https://www.optimi.net ↗

Optimi Health Corp. is a Canadian GMP manufacturer and supplier of psychedelic substances, offering formulation, APIs, and drug products from preclinical to commercial stages, including botanical psilocybin and MDMA.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT OPTIMI HEALTH CORP. IS KNOWN FOR

MDMA 60 mg and MDMA 40 mg capsules
MDMA 60 mg and MDMA 40 mg capsules

Optimi Health Corp. manufactures and supplies GMP-grade MDMA capsules for PTSD treatment to authorized Australian psychiatrists under the Therapeutic Goods Administration's scheme.

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book3
Overall Score1